Flu

While most COVID-19 mutations do not affect disease severity, some may have made it more contagious.

By simulating inhalation, exhalation, coughs, and sneezes in the laboratory, the researchers discovered that non-woven fabrics used in most masks work well to demonstrate the concept.

Study shows that 61% of patients who either were not prescribed CPAP to treat their sleep apnea or were not adherent to their CPAP treatment were hospitalized with influenza.

Investigators demonstrated that protection from COVID-19 transmission increases with physical distancing in an approximately linear proportion.

Questions remain whether recovered COVID-19 patients who test positive are still contagious.

Study shows large reductions in visits to essential stores during the pandemic, such as pharmacies, but found essentially no reduction in non-essential visits to parks and other outdoor spots.

Using several sources of data, researchers at Linköping University in Sweden developed a new method to predict flu epidemics.

Study suggests COVID-19 cases and deaths in the United States in the fall and winter will far exceed those of spring 2020 unless there is effective implementation of nationally coordinated efforts and preventive strategies.

A new study found that the COVID-19 death rate in New York has dropped significantly since March.

The impact of engineering controls, such as ventilation systems, is greater on limiting the spread of COVID-19 than the impact of the most widely applied measures.

Patients with mild or no symptoms of COVID-19 may be infectious for just 10 days.

They can help patients improve inhalation technique, ensuring better medication adherence.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Thirty-four percent of people in Turkey and 17% of people in the UK report that they are “hesitant” about a COVID-19 vaccine, primarily based on the their beliefs regarding the origin of the virus.

Physicians and scientists tested several oral and nasopharyngeal rinses in a laboratory setting for their ability to inactivate human coronaviruses that are similar in structure to SARS-CoV-2.

According to Amy Kallo, a PharmD student at Midwestern University, working at a pharmacy during the pandemic helped to solidify her understanding of the role of pharmacists as educators in their communities.

Barring a successful vaccine, COVID-19 may experience a yearly outbreak similar to the flu.

In 2019, the independent community pharmacy industry represented 35% of all retail pharmacies in the United States with a $73.7 billion marketplace, according to the NCPA’s recently released 2020 NCPA Digest.

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

The combination of isolating potentially sick patients in their car and conducting the test in a ventilated setting minimizes COVID-19 transmission to the rest of the population.

Data from all 50 states and the District of Columbia showed a gradual, steady decline in viral transmission rates during the 8 weeks immediately preceding relaxation of physical distancing rules.

Given the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.

Those hospitalized for COVID-19 are, on average, younger and healthier than hospitalized flu patients.

By using a positive outlook on these circumstances, pharmacy students can learn many lessons that will set them up for success in the future.

Patients treated with remdesivir achieved a median time to recovery of 10 days with remdesivir, compared with 15 days on the placebo.

A new study suggests that COVID-19 relieves pain, which is why many patients do not experience any symptoms.

A new study suggests that blood pressure medication may help reduce influenza deaths.

A new study contradicts the popular belief that COVID-19 is spread through close contact with droplets.